ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Uterine Fibroids
Interventions
DEVICE

ExAblate Treatment UF V2

Treatment with the ExAblate UF V2 system. Patients may have up to two ExAblate treatments within a two-week period.

Trial Locations (8)

22908

University of Virginia Health System, Charlottesville

27705

Duke University, Durham

43214

Ohio Health Research Institute, Columbus

55905

Mayo Clinic, Rochester

90095

University of California, Los Angeles, Los Angeles

94107

University of California, San Francisco, San Francisco

94305

Stanford University Medical Center, Stanford

02115

Brigham and Women's Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

InSightec

INDUSTRY